Gary Glausser
Partner @ Birchmere Ventures
Pittsburgh, United States
Gary Glausser is a Series A investor at Birchmere Ventures in Pittsburgh focused on Health Care and Medical Device. Gary Glausser is the Managing Director at Riverfront Ventures.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Gary Glausser invests in
Stages Gary Glausser invests in
Countries Gary Glausser invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- Medical Device 2 (50%)
- Medical 1 (25%)
- Therapeutics 1 (25%)
- Biotechnology 1 (25%)
Stage
- Series A 2 (50%)
- Series B 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placedwithin the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania. | $15.8M / Series B / Sep 11, 2013 | ||
| ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placedwithin the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania. | $10M / Series B / Feb 06, 2012 | ||
| ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placedwithin the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania. | $14M / Series A / Oct 11, 2010 | ||
| Renal Solutions is focused on the development of dialysis products and services. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Renal Solutions was founded in 2000 and is based in Warrendale, Pennsylvania. | $14.7M / Series A / Dec 03, 2002 |
Co-Investors
Eagle Ventures
3 deals together
MAG Ventures
2 deals together
Accelerator Fund
1 deal together
Allos Ventures
1 deal together
Amkey Ventures
1 deal together
Blue Chip Venture Company
1 deal together
About Birchmere Ventures
Across five funds and two decades, we've helped build numerous successful companies such as Cvent (event management - IPO) , TenMarks (math tutoring - acquired by Amazon) CyOptics (optical chips - acquired by Avago), Neolinear (EDA - acquired by Cadence), and FreeMarkets (B2B marketplace - IPO).We believe great companies can start anywhere(but to scale quickly they may require a coastal presence), and the best engineers and scientists do not go to just a few schools on each coast. These core principles lead us to invest in companies from across the country overlooked by many other investors, uncovering hidden gems and helping them scale up.
Birchmere Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ned Renzi
Fouding Partner
|
|||
Sean Sebastian
Partner
|
|||
Ivan Koon
Venture Partner
|
|||
Sean Ammirati
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Gary Glausser invest in?
Gary Glausser invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gary Glausser?
Public channels for Gary Glausser include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gary Glausser last invest?
The most recent investment recorded for Gary Glausser closed in Sep 2013. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
